Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Remifentanil

S S Patel1, C M Spencer

  • 1Adis International Limited, Auckland, New Zealand.

Drugs
|September 1, 1996
PubMed
Summary
This summary is machine-generated.

Remifentanil, a potent mu-opioid agonist, offers rapid onset and offset, enabling precise control during surgery. Its unique metabolism ensures quick recovery, making it ideal for intraoperative analgesia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Whole genome sequencing and characteristics of extended-spectrum beta-lactamase producing <i>Escherichia coli</i> isolated from poultry farms in Banaskantha, India.

Frontiers in microbiology·2022
Same author

Visuomotor control in mice and primates.

Neuroscience and biobehavioral reviews·2021
Same author

Technique to manage intraoperative cuff leak from damaged endotracheal tube pilot balloon.

International journal of oral and maxillofacial surgery·2021
Same author

Metagenomic of clinically diseased and healthy broiler affected with respiratory disease complex.

Data in brief·2018
Same author

Improving bone marrow biopsy quality through peer discussion and data comparisons: A single institution experience.

International journal of laboratory hematology·2018
Same author

Complete Genome Sequence of Brucella abortus SKN 13 Isolated from Placenta of Aborted Cattle in Gujarat, India.

Genome announcements·2016
Same journal

The Long Road to Long-Acting: What Oral PrEP and CAB-LA Teach Us About Scaling Lenacapavir.

Drugs·2026
Same journal

Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

Drugs·2026
Same journal

Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

Drugs·2026
Same journal

Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

Drugs·2026
Same journal

Relacorilant: First Approval.

Drugs·2026
Same journal

Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases.

Drugs·2026
See all related articles

Area of Science:

  • Anesthesiology and Pharmacology

Background:

  • Remifentanil is a novel mu-opioid receptor agonist with high potency.
  • Its pharmacological profile is similar to other opioids like alfentanil.

Purpose of the Study:

  • To evaluate the unique pharmacokinetic and pharmacodynamic properties of remifentanil.
  • To highlight its advantages in intraoperative anesthesia and postoperative pain management.

Main Methods:

  • Pharmacokinetic and pharmacodynamic analysis of remifentanil.
  • Comparison with existing opioid analgesics.

Main Results:

  • Remifentanil is rapidly hydrolyzed by plasma and tissue esterases, leading to short duration of action.
  • It provides precise, titratable effects with rapid onset and offset, independent of infusion duration.

Related Experiment Videos

  • Remifentanil demonstrates non-cumulative effects and allows for rapid patient recovery.
  • It also exhibits a sparing effect on hypnotics and sedatives.
  • Conclusions:

    • Remifentanil's unique pharmacokinetic profile allows for real-time management of intraoperative stress.
    • Its rapid offset necessitates establishing postoperative analgesia before discontinuation.
    • Remifentanil offers optimal intraoperative analgesia without compromising recovery for various surgical procedures.